NeuroPace (NPCE) Reports In-Line Q1 EPS, provides guidance

NeuroPace (NASDAQ: NPCE) reported Q1 EPS of ($0.32), in-line with the analyst estimate of ($0.32). Revenue for the quarter came in at $18.1 million versus the consensus estimate of $17.33 million.

GUIDANCE:

NeuroPace sees FY2024 revenue of $73-77 million, versus the consensus of $75.209 million.
Gross margin to range between 72% and 74%
Total operating expenses to range between $80 million and $84 million, including approximately $12 million in stock-based compensation, a noncash expense

For earnings history and earnings-related data on NeuroPace (NPCE) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30